Ovarian reserve in patients with ankylosing spondylitis

In: Archives of Gynecology and Obstetrics · 2020 · vol. 303(1) , pp. 189–193 · doi:10.1007/s00404-020-05824-8 · PMID:33030584 · W3092322373
article OA: closed CC0 ⤵ 1 in-corpus citation
AI-generated summary by qwen3.7-flash, 2026-08-18

This study found that women with ankylosing spondylitis exhibit significantly lower ovarian reserve markers, including anti-Müllerian hormone and antral follicle count, compared to controls, indicating adverse effects on fertility potential.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-18 · read from full text

This study evaluated the impact of ankylosing spondylitis on female fertility potential by comparing ovarian reserve markers between 52 patients with the condition and 52 healthy controls. Researchers measured serum anti-Müllerian hormone levels, antral follicle count, and baseline follicle-stimulating hormone levels to assess reproductive health. The results indicated that women with ankylosing spondylitis had significantly lower anti-Müllerian hormone levels and antral follicle counts than the control group, suggesting adverse effects on ovarian reserve. This paper is centrally about endometriosis — specifically laparoscopic excision of deep infiltrating lesions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PurposeThe aim of this study was to determine the autoimmune effects of ankylosing spondylitis (AS) on the fertility potential of women by evaluating ovarian reserves of AS patients.MethodsA total of 104 patients, 52 in the AS group (study group) and 52 in the control group were included in the study. Ovarian reserve was evaluated by serum anti-Müllerian hormone (AMH) levels, antral follicle count (AFC) and baseline serum follicle-stimulating hormone (FSH) levels.ResultsThe mean serum AMH levels were significantly lower in the study group when compared to the controls (2.203 ± 1.110 vs. 1.188 ± 0.891, p < 0.001). In addition, the mean AFC was also significantly lower in the study group. (10.67 ± 1.81 vs. 9.54 ± 2.50, p = 0.009). Mean FSH levels were calculated to be 6.72 ± 1.14 in the study group and 7.21 ± 1.22 in the control group. The difference was not statistically significant (p = 0.781).ConclusionThis study shows that AS like several other autoimmune conditions has an adverse effect on the female fertility potential. Therefore, an early start and long-term management of AS patients who have fertility desire is recommended. Serum AMH levels can be used in monitoring ovarian reserve and in early detection of reproductive decline of AS patients.Clinicaltrial numberNCT04209881.
Full text 8,288 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Purpose The aim of this study was to determine the autoimmune effects of ankylosing spondylitis (AS) on the fertility potential of women by evaluating ovarian reserves of AS patients.

Methods

A total of 104 patients, 52 in the AS group (study group) and 52 in the control group were included in the study. Ovarian reserve was evaluated by serum anti-Müllerian hormone (AMH) levels, antral follicle count (AFC) and baseline serum follicle-stimulating hormone (FSH) levels.

Results

The mean serum AMH levels were significantly lower in the study group when compared to the controls (2.203 ± 1.110 vs. 1.188 ± 0.891, p < 0.001). In addition, the mean AFC was also significantly lower in the study group. (10.67 ± 1.81 vs. 9.54 ± 2.50, p = 0.009). Mean FSH levels were calculated to be 6.72 ± 1.14 in the study group and 7.21 ± 1.22 in the control group. The difference was not statistically significant (p = 0.781).

Conclusion

This study shows that AS like several other autoimmune conditions has an adverse effect on the female fertility potential. Therefore, an early start and long-term management of AS patients who have fertility desire is recommended. Serum AMH levels can be used in monitoring ovarian reserve and in early detection of reproductive decline of AS patients. ClinicalTrial Number NCT04209881. Similar content being viewed by others

References

Barbieri RL (2014) The endocrinology of the menstrual cycle. Methods Mol Biol 1154:145–169. https://doi.org/10.1007/978-1-4939-0659-8_7 Vannuccini S, Clifton VL, Fraser IS, Taylor HS, Critchley H, Giudice LC, Petraglia F (2016) Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Human reproduction update 22(1):104–115 Cordts EB, Christofolini DM, dos Santos AA, Bianco B, Barbosa CP (2011) Genetic aspects of premature ovarian failure: a literature review. Arch Gynecol Obstet 283(3):635–643 Komorowska B (2016) Autoimmune premature ovarian failure. Przeglad menopauzalny. Menopause Rev 15(4):210 de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL (2016) Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthrt Res Thera 18(1):196 Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ (2014) Global prevalence of ankylosing spondylitis. Rheumatology 53(4):650–657 Mohan MP, Ramesh TC (2003) Multiple autoimmune syndrome. Indian J Dermatol Venereol Leprol 69(4):298 Brouwer J, Laven JS, Hazes JM, Schipper I, Dolhain RJ (2013) Levels of serum anti–Müllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res 65(9):1534–1538 Şahin A, Karakuş S, Durmaz Y, Yıldız Ç, Aydın H, Cengiz AK, Güler D (2015) Evaluation of ovarian reserve with anti-müllerian hormone in familial Mediterranean fever. International journal of rheumatology 5:3 del Carmen Velarde-Ochoa M, Esquivel-Valerio JA, Vega-Morales D, Skinner-Taylor CM, Galarza-Delgado DÁ, Garza-Elizondo MA (2015) Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus. Reumatología Clínica (English Edition) 11(2):78–82 Tuten A, Hatipoglu E, Oncul M, Imamoglu M, Acikgoz AS, Yilmaz N, Sahmay S (2014) Evaluation of ovarian reserve in Hashimoto’s thyroiditis. Gynecol Endocrinol 30(10):708–711 Karakus S, Sahin A, Durmaz Y et al (2017) Evaluation of ovarian reserve using anti-müllerian hormone and antral follicle count in Sjögren's syndrome: preliminary study. J Obstet Gynaecol Res 43(2):303–307. https://doi.org/10.1111/jog.13216 Vural B, Cakiroglu Y, Vural F, Filiz S (2014) Hormonal and functional biomarkers in ovarian response. Arch Gynecol Obstet 289(6):1355–1361 Silva CAA, Brunner HI (2007) Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 16(8):593–599 Fleming R, Seifer DB, Frattarelli JL, Ruman J (2015) Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reproduct Biomed Online 31(4):486–496 Karakus S, Sahin A, Durmaz Y, Aydin H, Yildiz C, Akkar O, Cetin A (2017) Evaluation of ovarian reserve using anti-müllerian hormone and antral follicle count in Sjögren's syndrome: preliminary study. J Obstet Gynaecol Res 43(2):303–307 Linden SVD, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. Arthrit Rheum 27(4):361–368 Vignali M, Belloni GM, Pietropaolo G, Barbasetti Di Prun A, Barbera V, Angioni S, Pino I (2020) Effect of Dienogest therapy on the size of the endometrioma. Gynecol Endocrinol 1:1–5 Tomassetti C, D'Hooghe T (2018) Endometriosis and infertility: Insights into the causal link and management strategies. Best Pract Res Clin Obstet Gynaecol 51:25–33. https://doi.org/10.1016/j.bpobgyn.2018.06.002 de Vet A, Laven J, de Jong F, Themmen A, Fauser B (2019) Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 112(4):E183–E188 Anjum S, Zahra F, Yousuf SM (2019) Ovarian reserve parameters and response to controlled ovarian stimulation in infertile patients. Pak J Med Sci 35(4):958 Practice Committee of the American Society for Reproductive Medicine (2015) Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 103(3):e9–e17 Porcu E, Cillo GM, Cipriani L, Sacilotto F, Notarangelo L, Damiano G, Roncarati I (2019) Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer. J Assist Reproduct Gene 1:1–7 Schoemaker J, Drexhage H, Hoek A (1997) Premature ovarian failure and ovarian autoimmunity. Endocrine Rev 10:106–123 Silva CA, Yamakami LYS, Aikawa NE, Araujo DB, Carvalho JF, Bonfá E (2014) Autoimmune primary ovarian insufficiency. Autoimmun Rev 13(4–5):427–430 Tapia-Serrano R, Jimenez-Balderas FJ, Murrieta S, Bravo-Gatica C, Guerra R, Mintz G (1991) Testicular function in active ankylosing spondylitis. Therapeutic response to human chorionic gonadotrophin. J Rheumatol 18(6):841–848 Gooren LJ, Giltay EJ, van Schaardenburg D, Dijkmans BA (2000) Gonadal and adrenal sex steroids in ankylosing spondylitis. Rheumatic Dis Clin North Am 26(4):969–987 Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. The Lancet 301(7809):904–907 Carter N, Williamson L, Kennedy LG, Brown MA, Wordsworth BP (2000) Susceptibility to ankylosing spondylitis. Rheumatology 39(4):445–445 Taurog JD (2007) The mystery of HLA–B27: if it isn't one thing, it's another. Arthritis Rheum 56(8):2478–2481 Sen A, Kushnir VA, Barad DH, Gleicher N (2014) Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol 10(1):37 Yun BH, Kim G, Park SH, Noe EB, Seo SK, Cho S, Lee BS (2017) In vitro fertilization outcome in women with diminished ovarian reserve. Obstet Gynecol Sci 60(1):46–52 Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Author information Authors and Affiliations Contributions PYB: study designation and manuscript writing; PK: manuscript writing and statistical analysis; BY: data interpretation; EÜÖ: laboratory analysis; KÇ: statistical analysis; NFTS: critically revised the article and supervised the study. Corresponding author Ethics declarations Conflict of interest The authors have no conflict of interest to declare. Ethics approval The Institutional Review Board of Health Science University Istanbul Sadi Konuk Training and Research Hospital, Istanbul, Turkey approved this study (IRB Approval Number: 2019/456,). Informed consent Informed consent was obtained from all individual participants included in the study. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions About this article Cite this article Yalçın Bahat, P., Kadiroğulları, P., Topbas Selcuki, N.F. et al. Ovarian reserve in patients with ankylosing spondylitis. Arch Gynecol Obstet 303, 189–193 (2021). https://doi.org/10.1007/s00404-020-05824-8 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00404-020-05824-8

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

References (38)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-11T06:35:44.859312+00:00
unpaywall
last seen: 2026-08-26T06:23:03.089193+00:00
License: CC0 · commercial use OK